The effect of angiogenesis inhibitor TNP-470 on the blood vessels of the lungs, kidneys and livers of treated hamsters

Folia Morphologica

Volumn 63, Issue 1, 2004, Pages 5-9

  Myśliwski, Andrzej ^a   Kubasik Juraniec, Jolanta ^a   Koszałka, Patrycja ^a   Szmit, Ewa ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Blood vessels; Hamster; TNP 470 Melanoma

Indexed keywords

ALCOHOL; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; FUMAGILLOL CHLOROACETYLCARBAMATE; GUM ARABIC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER REGRESSION; CONTROLLED STUDY; ELECTRON MICROSCOPY; HAMSTER; KIDNEY BLOOD VESSEL; LIVER BLOOD VESSEL; LUNG BLOOD VESSEL; MALE; MELANOMA; MICROSCOPY; MORPHOLOGY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; SURVIVAL TIME;

ANGIOGENESIS INHIBITORS; ANIMALS; BLOOD VESSELS; CRICETINAE; CYCLOHEXANES; KIDNEY; KIDNEY GLOMERULUS; LIVER; LUNG; MALE; MELANOMA, EXPERIMENTAL; MESOCRICETUS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; SESQUITERPENES;

ANIMALIA; CRICETINAE;

EID: 1542315307     PISSN: 00155659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bhargava P, Marshall JL, Rizivi N, Dahut W, Yoe, Figuera M, Phipps K, Ong VS, Kato A, Hawkins (1999) A phase I and pharmacokinetic study of TNP-470 administrated weekly to patients with advanced cancer. Clin Cancer Res, 5: 1989-1995.
2. Bomirski A, Slominski A, Bigda J (1988) The natural history of a family of transplantable melanomas in hamsters. Cancer Metastasis Rev, 7: 95-118.
3. Castronovo V, Belotti D (1996) TNP-470 (AGM-1470): Mechanism of action and early clinical development. Eur J Cancer, 32A: 2520-2527.
4. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst, 82: 4-6.
5. Folkman J (1992) Tumor angiogenesis and tissue factor. Nature Med, 2: 167-168.
6. Gervaz P, Fontolliet M (1998) Therapeutic potential of the anti-angiogenesis drug TNP-470. Int J Exp Pathol, 79: 359-362.
7. Hotz HG, Reber HA, Hotz B, Sanghavi PC, Yu T, Foitzik T, Buhr HJ, Hines OJ (2001) Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth. J Gastrointest Surg, 5: 131-138.
8. Ingbar D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J (1990) Synthetic analogues of fumagilin that inhibit angiogenesis and suppress tumor growth. Nature, 348: 555-557.
9. Kusaka M, Sudo K, Matsutani E, Kozai Y, Marui S, Fujita T, Ingbar D, Folkman J (1994) Cytostatic inhibition of endothelial cell growth by angiogenesis inhibitor TNP-470 (AGM-1470). Br J Cancer, 69: 212-216.
10. Mahadevan V, Hart IR (1990) Matastasis and angiogenesis. Acta Oncol, 29: 97-103.
11. Masunaga S, Ono K, Nishimura Y, Kanamori S, Saga T, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y, Hori H (2000) Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells. Int J Radiation Oncology Biol Phys, 47: 799-807.
12. Myśliwski A, Szmit E, Szatkowski D, Sosonowska D (1998) Suppression of growth of Bomirski Ab melanoma and its metastasis in hamsters by angiogenesis inhibitor TNP-470. Anticancer Res, 18: 441-444.
13. Myśliwski A, Bigda J, Koszałka P, Szmit E (2000) Synergistic effect of the agniogenesis inhibitor TNP-470 and Tumor Necrosis Factor (TNF) on Bomirski Ab melanoma in hamsters. Anticancer Res, 20: 4643-4648.
14. Myśliwski P, Koszałka P, Bigda J, Szmit E (2002) Complete remission of Bomirski Ab amelanotic melanoma in hamsters treated with the angiogenesis inhibitor TNP-470. Neoplasma, 49: 319-322.